-
1
-
-
0024814687
-
Model predicting survival in stage I melanoma based on tumor progression
-
Clark, W.H., Jr., D.E. Elder, D. Guerry IV, L.E. Braitman, B.J. Trock, D. Schultz, M. Synnestvedt, and A.C. Halpern. 1989. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81:1893-1904.
-
(1989)
J. Natl. Cancer Inst.
, vol.81
, pp. 1893-1904
-
-
Clark W.H., Jr.1
Elder, D.E.2
Guerry D. IV3
Braitman, L.E.4
Trock, B.J.5
Schultz, D.6
Synnestvedt, M.7
Halpern, A.C.8
-
2
-
-
0030052833
-
Tumor infiltrating lymphocytes in lymph node melanoma metastases: A histopathologic prognostic indicator and an expression of local immune response
-
Mihm, M., C. Clemente, and N. Cascinelli. 1996. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab. Invest. 74:43-47.
-
(1996)
Lab. Invest.
, vol.74
, pp. 43-47
-
-
Mihm, M.1
Clemente, C.2
Cascinelli, N.3
-
3
-
-
0028826973
-
Analysis of TCR usage in human tumors: A new tool for assessing tumor-specific immune responses
-
Sensi, M.L., and G. Parmiani. 1995. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today. 16:588-595.
-
(1995)
Immunol. Today.
, vol.16
, pp. 588-595
-
-
Sensi, M.L.1
Parmiani, G.2
-
4
-
-
0028942142
-
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in-vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1
-
Rivoltini, L., Y. Kawakami, K. Sakaguchi, S. Southwood, A. Sette, P.F. Robbins, F.M. Marincola, M.L. Salgaller, J.R. Yannelli, E. Appella, et al. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in-vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154:2257-2265.
-
(1995)
J. Immunol.
, vol.154
, pp. 2257-2265
-
-
Rivoltini, L.1
Kawakami, Y.2
Sakaguchi, K.3
Southwood, S.4
Sette, A.5
Robbins, P.F.6
Marincola, F.M.7
Salgaller, M.L.8
Yannelli, J.R.9
Appella, E.10
-
5
-
-
0028871599
-
Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in-vitro with synthetic peptides
-
Salgaller, M.L., A. Afshar, F.M. Marincola, L. Rivoltini, Y. Kawakami, and S.A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in-vitro with synthetic peptides. Cancer Res. 55:4972-4979.
-
(1995)
Cancer Res.
, vol.55
, pp. 4972-4979
-
-
Salgaller, M.L.1
Afshar, A.2
Marincola, F.M.3
Rivoltini, L.4
Kawakami, Y.5
Rosenberg, S.A.6
-
6
-
-
0030029651
-
Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A*0201-restricted immune repertoire to melanoma
-
Anichini, A., R. Mortarini, C. Maccalli, P. Squarcina, K. Fleischhauer, L. Mascheroni, and G. Parmiani. 1996. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A*0201-restricted immune repertoire to melanoma. J. Immunol. 156:208-217.
-
(1996)
J. Immunol.
, vol.156
, pp. 208-217
-
-
Anichini, A.1
Mortarini, R.2
Maccalli, C.3
Squarcina, P.4
Fleischhauer, K.5
Mascheroni, L.6
Parmiani, G.7
-
7
-
-
0029835516
-
Differential anti-Mart-1/Melan-A CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison with healthy donors: Evidence of in-vivo priming by tumor cells
-
Marincola, F.M., L. Rivoltini, M.L. Salgaller, M. Player, and S.A. Rosenberg. 1996. Differential anti-Mart-1/Melan-A CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison with healthy donors: evidence of in-vivo priming by tumor cells. J. Immunother. 19:266-277.
-
(1996)
J. Immunother.
, vol.19
, pp. 266-277
-
-
Marincola, F.M.1
Rivoltini, L.2
Salgaller, M.L.3
Player, M.4
Rosenberg, S.A.5
-
8
-
-
0003077969
-
Cutaneous melanoma
-
V.T. De Vita, S. Hellman, and S.A. Rosenberg, editors. Lippincott-Raven
-
Balch, C.M., D.S. Reintgen, J.M. Kirkwood, A. Houghton, L. Peters, and K.K. Ang. 1997. Cutaneous melanoma. In Cancer Principles & Practice of Oncology, 5th Ed. V.T. De Vita, S. Hellman, and S.A. Rosenberg, editors. Lippincott-Raven. 1947-1994.
-
(1997)
Cancer Principles & Practice of Oncology, 5th Ed.
, pp. 1947-1994
-
-
Balch, C.M.1
Reintgen, D.S.2
Kirkwood, J.M.3
Houghton, A.4
Peters, L.5
Ang, K.K.6
-
9
-
-
0029924107
-
Human tumor antigens recognized by T lymphocytes
-
Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 83:725-729.
-
(1996)
J. Exp. Med.
, vol.83
, pp. 725-729
-
-
Boon, T.1
Van Der Bruggen, P.2
-
10
-
-
0033103021
-
A new era for cancer immunotherapy based on the genes that encode cancer antigens
-
Rosenberg, S.A. 1999. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 10:281-287.
-
(1999)
Immunity.
, vol.10
, pp. 281-287
-
-
Rosenberg, S.A.1
-
11
-
-
0028302028
-
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
-
Kawakami, Y., S. Eliyahu, K. Sakaguchi, P.F. Robbins, L. Rivoltini, J.R. Yannelli, E. Appella, and S.A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-352.
-
(1994)
J. Exp. Med.
, vol.180
, pp. 347-352
-
-
Kawakami, Y.1
Eliyahu, S.2
Sakaguchi, K.3
Robbins, P.F.4
Rivoltini, L.5
Yannelli, J.R.6
Appella, E.7
Rosenberg, S.A.8
-
12
-
-
8944254243
-
Analysis of expression of the melanoma associated antigens Mart-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
-
Marincola, F.M., Y. Hijazi, P. Fetsch, M.L. Salgaller, L. Rivoltini, J. Cormier, T.B. Simonis, P.H. Duray, M. Herlyn, Y. Kawakami, et al. 1996. Analysis of expression of the melanoma associated antigens Mart-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. J. Immunother. 19: 192-205.
-
(1996)
J. Immunother.
, vol.19
, pp. 192-205
-
-
Marincola, F.M.1
Hijazi, Y.2
Fetsch, P.3
Salgaller, M.L.4
Rivoltini, L.5
Cormier, J.6
Simonis, T.B.7
Duray, P.H.8
Herlyn, M.9
Kawakami, Y.10
-
13
-
-
0020546352
-
The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells
-
Russo, C., A.K. Ng, M.A. Pellegrino, and S. Ferrone. 1983. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics. 18:23-35.
-
(1983)
Immunogenetics
, vol.18
, pp. 23-35
-
-
Russo, C.1
Ng, A.K.2
Pellegrino, M.A.3
Ferrone, S.4
-
14
-
-
0026560192
-
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes
-
Morrison, J., J. Elvin, F. Latron, F. Gotch, R. Moots, J.L. Strominger, and A. McMichael. 1992. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur. J. Immunol. 22:903-907.
-
(1992)
Eur. J. Immunol.
, vol.22
, pp. 903-907
-
-
Morrison, J.1
Elvin, J.2
Latron, F.3
Gotch, F.4
Moots, R.5
Strominger, J.L.6
McMichael, A.7
-
15
-
-
0028347940
-
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes
-
Wolfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.H.M. zum Buschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24:759-764.
-
(1994)
Eur. J. Immunol.
, vol.24
, pp. 759-764
-
-
Wolfel, T.1
Van Pel, A.2
Brichard, V.3
Schneider, J.4
Seliger, B.5
Zum Buschenfelde, K.H.M.6
Boon, T.7
-
16
-
-
0031440468
-
27-35-specific CTL from PBL of melanoma patients with low frequency of CTL precursors
-
27-35-specific CTL from PBL of melanoma patients with low frequency of CTL precursors. Cancer Res. 57:5534-5541.
-
(1997)
Cancer Res.
, vol.57
, pp. 5534-5541
-
-
Mortarini, R.1
Anichini, A.2
Di Nicola, M.3
Siena, S.4
Bregni, M.5
Belli, F.6
Molla, A.7
Gianni, A.M.8
Parmiani, G.9
-
17
-
-
0027444584
-
Characterization of cytotoxic T lymphocyte epitopes of a self protein, p53, and a non-self protein, influenza matrix: Relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides
-
Nijman, H.W., J.G.A. Houbiers, S.H. Van der Burg, M.P.M. Vierboom, P. Kenemans, W.M. Kast, and C.J. Melief. 1993. Characterization of cytotoxic T lymphocyte epitopes of a self protein, p53, and a non-self protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides. J. Immunother. 14:121-126.
-
(1993)
J. Immunother.
, vol.14
, pp. 121-126
-
-
Nijman, H.W.1
Houbiers, J.G.A.2
Van Der Burg, S.H.3
Vierboom, M.P.M.4
Kenemans, P.5
Kast, W.M.6
Melief, C.J.7
-
18
-
-
0032555910
-
High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
-
Ogg, G.S., P.R. Dunbar, P. Romero, J.L. Chen, and V. Cerundolo. 1998. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188:1203-1208.
-
(1998)
J. Exp. Med.
, vol.188
, pp. 1203-1208
-
-
Ogg, G.S.1
Dunbar, P.R.2
Romero, P.3
Chen, J.L.4
Cerundolo, V.5
-
19
-
-
0032520084
-
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/Mart-1 immunodominant peptide analogues
-
Valmori, D., J.F. Fontaneau, C.M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J.C. Cerottini, and P. Romero. 1998. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/Mart-1 immunodominant peptide analogues. J. Immunol. 160:1750-1758.
-
(1998)
J. Immunol.
, vol.160
, pp. 1750-1758
-
-
Valmori, D.1
Fontaneau, J.F.2
Lizana, C.M.3
Gervois, N.4
Lienard, D.5
Rimoldi, D.6
Jongeneel, V.7
Jotereau, F.8
Cerottini, J.C.9
Romero, P.10
-
20
-
-
0032602027
-
Melan-A, a new melanocytic differentiation marker
-
Busam, K.J., and A.A. Jungbluth. 1999. Melan-A, a new melanocytic differentiation marker. Adv. Anal. Pathol. 6:12-18.
-
(1999)
Adv. Anal. Pathol.
, vol.6
, pp. 12-18
-
-
Busam, K.J.1
Jungbluth, A.A.2
-
21
-
-
0028068922
-
Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: Limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients
-
Mazzocchi, A., F. Belli, L. Mascheroni, C. Vegetti, G. Parmiani, and A. Anichini. 1994. Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients. Int. J. Cancer. 58:330-339.
-
(1994)
Int. J. Cancer.
, vol.58
, pp. 330-339
-
-
Mazzocchi, A.1
Belli, F.2
Mascheroni, L.3
Vegetti, C.4
Parmiani, G.5
Anichini, A.6
-
23
-
-
0029847966
-
+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes
-
+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:8165-8168.
-
(1996)
J. Virol.
, vol.70
, pp. 8165-8168
-
-
Posavad, C.M.1
Koelle, D.M.2
Corey, L.3
-
24
-
-
0028835980
-
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides
-
Cerny, A., J.G. McHutchinson, C. Pasquinelli, M.E. Brown, M.A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F.V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides. J. Clin. Invest. 95:521-530.
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 521-530
-
-
Cerny, A.1
McHutchinson, J.G.2
Pasquinelli, C.3
Brown, M.E.4
Brothers, M.A.5
Grabscheid, B.6
Fowler, P.7
Houghton, M.8
Chisari, F.V.9
-
26
-
-
0032485487
-
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
-
Albert, M.L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:86-89.
-
(1998)
Nature
, vol.392
, pp. 86-89
-
-
Albert, M.L.1
Sauter, B.2
Bhardwaj, N.3
-
27
-
-
0029842830
-
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
-
Gabrilovich, D.I., H.L. Chen, K.R. Girgis, H.T. Cunningham, G.M. Meny, S. Nadaf, D. Kavanaugh, and D.P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1096-1103.
-
(1996)
Nat. Med.
, vol.2
, pp. 1096-1103
-
-
Gabrilovich, D.I.1
Chen, H.L.2
Girgis, K.R.3
Cunningham, H.T.4
Meny, G.M.5
Nadaf, S.6
Kavanaugh, D.7
Carbone, D.P.8
-
28
-
-
0029788301
-
27-35)
-
27-35). J. Exp. Med. 184:647-657.
-
(1996)
J. Exp. Med.
, vol.184
, pp. 647-657
-
-
Loftus, D.J.1
Castelli, C.2
Clay, T.M.3
Squarcina, P.4
Marincola, F.M.5
Nishimura, M.I.6
Parmiani, G.7
Appella, E.8
Rivoltini, L.9
-
29
-
-
0032100538
-
27-35)
-
27-35). Cancer Res. 58:2433-2439.
-
(1998)
Cancer Res.
, vol.58
, pp. 2433-2439
-
-
Loftus, D.J.1
Squarcina, P.2
Nielsen, M.B.3
Geisler, C.4
Castelli, C.5
Odum, N.6
Appella, E.7
Parmiani, G.8
Rivoltini, L.9
-
31
-
-
0031027541
-
+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients
-
+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin. Cancer Res. 3:221-226.
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 221-226
-
-
Scheibenbogen, C.1
Lee, K.H.2
Mayer, S.3
Stevanovic, S.4
Moebius, U.5
Herr, W.6
Rammensee, H.G.7
Keilholz, U.8
-
32
-
-
0032568259
-
Direct isolation, phenotyping and cloning of low frequency antigen-specific CTL from peripheral blood
-
Dunbar, P.R., G.S. Ogg, J. Chen, N. Rust, P. van der Bruggen, and V. Cerundolo. 1998. Direct isolation, phenotyping and cloning of low frequency antigen-specific CTL from peripheral blood. Curr. Biol. 8:413-416.
-
(1998)
Curr. Biol.
, vol.8
, pp. 413-416
-
-
Dunbar, P.R.1
Ogg, G.S.2
Chen, J.3
Rust, N.4
Van Der Bruggen, P.5
Cerundolo, V.6
-
34
-
-
0028909051
-
Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ 17 gene segment
-
Lehner, P.J., E.G. Wang, P.A. Moss, S. Williams, K. Platt, S.M. Friedman, J.I. Bell, and L.K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ 17 gene segment. J. Exp. Med. 181:79-91.
-
(1995)
J. Exp. Med.
, vol.181
, pp. 79-91
-
-
Lehner, P.J.1
Wang, E.G.2
Moss, P.A.3
Williams, S.4
Platt, K.5
Friedman, S.M.6
Bell, J.I.7
Borysiewicz, L.K.8
-
35
-
-
0032476616
-
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
-
Romero, P., P.R. Dunbar, D. Valmori, M. Pittet, G.S. Ogg, D. Rimoldi, J.L. Chen, D. Lienard, J.C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1641-1650.
-
(1998)
J. Exp. Med.
, vol.188
, pp. 1641-1650
-
-
Romero, P.1
Dunbar, P.R.2
Valmori, D.3
Pittet, M.4
Ogg, G.S.5
Rimoldi, D.6
Chen, J.L.7
Lienard, D.8
Cerottini, J.C.9
Cerundolo, V.10
-
36
-
-
0031890206
-
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
-
Rosenberg, S.A., J.C. Yang, D.J. Schwartzentruber, P. Hwu, F.M. Marincola, S.L. Topalian, N.P. Restifo, M.E. Dudley, S.L. Schwarz, P.J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321-327.
-
(1998)
Nat. Med.
, vol.4
, pp. 321-327
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
Hwu, P.4
Marincola, F.M.5
Topalian, S.L.6
Restifo, N.P.7
Dudley, M.E.8
Schwarz, S.L.9
Spiess, P.J.10
-
37
-
-
0031941423
-
Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells
-
Nestle, F.O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328-332.
-
(1998)
Nat. Med.
, vol.4
, pp. 328-332
-
-
Nestle, F.O.1
Alijagic, S.2
Gilliet, M.3
Sun, Y.4
Grabbe, S.5
Dummer, R.6
Burg, G.7
Schadendorf, D.8
-
38
-
-
0029057043
-
Loss of HLA-class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
-
Ferrone, S., and F. Marincola. 1995. Loss of HLA-class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16:487-494.
-
(1995)
Immunol. Today.
, vol.16
, pp. 487-494
-
-
Ferrone, S.1
Marincola, F.2
-
39
-
-
0028829736
-
Alterations in T cell receptor and signal transduction molecules in melanoma patients
-
Zea, A.H., B.D. Cutri, D.L. Longo, W.G. Alvord, S.L. Strobl, H. Mizoguchi, S.P. Creekmore, J.J. O'Shea, G.C. Powers, W.J. Urba, et al. 1995. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res. 1:1327-1335.
-
(1995)
Clin. Cancer Res.
, vol.1
, pp. 1327-1335
-
-
Zea, A.H.1
Cutri, B.D.2
Longo, D.L.3
Alvord, W.G.4
Strobl, S.L.5
Mizoguchi, H.6
Creekmore, S.P.7
O'Shea, J.J.8
Powers, G.C.9
Urba, W.J.10
-
40
-
-
0031026259
-
Transfer of interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules
-
Guarini, A., L. Riera, A. Cignetti, L. Montacchini, M. Massaia, and R. Foa. 1997. Transfer of interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. Blood. 89:212-218.
-
(1997)
Blood
, vol.89
, pp. 212-218
-
-
Guarini, A.1
Riera, L.2
Cignetti, A.3
Montacchini, L.4
Massaia, M.5
Foa, R.6
|